Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “2019-nCoV (COVID-19)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT07089680
What this trial is testing

Learn About the Study Medicine Paxlovid (Nirmatrelvir + Ritonavir) in Adults Aged 60 and Older Living in Korean Long-term Care Hospitals Who Have COVID-19

Who this might be right for
Coronavirus Disease 2019 (COVID-19)
Pfizer 937
Not applicableUnknownNCT06204393
What this trial is testing

To Investigate the Effect of 2019 Novel Coronavirus Infection on the Condition of Patients With Hyperthyroidism

Who this might be right for
Graves DiseaseCOVID-19
Qilu Hospital of Shandong University 120
Not applicableNo Longer AvailableNCT05235347
What this trial is testing

Sotrovimab Expanded Access Treatment Protocol (COVID-19)

Who this might be right for
Covid19
Vir Biotechnology, Inc.
Not applicableEnded earlyNCT04937608
What this trial is testing

Impact of the Coronavirus Disease 2019 (COVID-19) on Sperm Parameters

Who this might be right for
Covid19Infertility, Male
Fertilys 2
Early research (Phase 1)WithdrawnNCT05178654
What this trial is testing

Study to Investigate the Mass Balance, Metabolism, and Excretion of [14C]PF-07321332 in Healthy Male Participants.

Who this might be right for
Healthy Participants
Pfizer
Not applicableStudy completedNCT04413435
What this trial is testing

Clinical Characteristics of Critically Ill Patients With COVID-19

Who this might be right for
Coronavirus InfectionCritical IllnessCharacteristics Disease
Nevsehir Public Hospital 105
Not applicableStudy completedNCT07072793
What this trial is testing

A US Study to Look at Loss of Work and Healthcare Costs for People Affected With Mild-to-moderate COVID 19 Who Have High Chances of the Disease Becoming Severe

Who this might be right for
COVID-19 (Coronavirus Disease 2019)
Pfizer 131,005
Not applicableStudy completedNCT04373759
What this trial is testing

Cardiac Arrest Incidence and Outcome Among Patients With COVID-19 in French ICUs

Who this might be right for
Sars-CoV2Covid-19
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 186
Testing effectiveness (Phase 2)Ended earlyNCT04482699
What this trial is testing

RAPA-501-Allo Therapy of COVID-19-ARDS

Who this might be right for
Severe COVID-19 Disease
Rapa Therapeutics LLC 1
Not applicableStudy completedNCT04611230
What this trial is testing

Assess Infection Rate of Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2) and It's Affect on Quality of Life in Adult Volunteers in Lake County, Illinois

Who this might be right for
Severe Acute Respiratory Syndrome - CoronaVirus 2 (SARS-CoV-2)
AbbVie 1,007
Not applicableUnknownNCT05092568
What this trial is testing

Comparison of General Characteristics of Patients Diagnosed COVID-19 (Coronavirus )Positive Followed In Service

Who this might be right for
Coronavirus Disease 2019VacciniaSymptoms and Signs
Saglik Bilimleri Universitesi 45
Not applicableLooking for participantsNCT05778006
What this trial is testing

Multi-Center Registry for ME/CFS

Who this might be right for
ME/CFSCFS/MEME/CFS Following EBV-associated Infectious Mononucleosis+1 more
Technical University of Munich 650
Large-scale testing (Phase 3)Study completedNCT04788355
What this trial is testing

Prevention of Complications (SARS-CoV-2): Clinical Study

Who this might be right for
Complication
Universidade do Vale do Sapucai 176
Testing effectiveness (Phase 2)Ended earlyNCT04668209
What this trial is testing

Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Coronavirus
University of Arizona 31
Not applicableUnknownNCT05831826
What this trial is testing

Effectiveness and Safety of the Inactivated COVID-19 Vaccine in Thousands of Patients With Autoimmune Diseases in China

Who this might be right for
COVID-19 VaccinesAutoimmune Diseases
Zhejiang Chinese Medical University 1,200
Not applicableStudy completedNCT05119348
What this trial is testing

Transmission of Coronavirus Disease 2019 (COVID19) in Crowded Environments

Who this might be right for
Covid19Sars-CoV-2 Infection
Desmond Tutu HIV Foundation 245
Not applicableUnknownNCT04380662
What this trial is testing

Risk Factors Worsening COVID19 for Out-patient With Home Monitoring

Who this might be right for
Covid19
University Hospital, Grenoble 800
Not applicableStudy completedNCT04259892
What this trial is testing

Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

Who this might be right for
Coronavirus
Institut National de la Santé Et de la Recherche Médicale, France 324
Early research (Phase 1)Study completedNCT07552779
What this trial is testing

How Ibuzatrelvir is Taken up Into the Blood of Healthy Adults After Taking Different Tablets of Ibuzatrelvir

Who this might be right for
Coronavirus Disease 2019Coronavirus Disease 2019 (COVID-19)COVID-19 (Coronavirus Disease 2019)+8 more
Pfizer 17
Early research (Phase 1)WithdrawnNCT04590274
What this trial is testing

Safety and Efficacy of Hydroxychloroquine for the Treatment & Prevention of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Who this might be right for
Covid19SARS (Severe Acute Respiratory Syndrome)
International Brain Research Foundation
Next Page